BeiGene names Ross Pettit as SVP, global development operations
Mr. Pettit has more than 30 years of experience in the biopharmaceutical industry, most recently at Infinity Pharmaceuticals where he was Senior Vice President of Development Operations and responsible for the execution of the company’s clinical programs including late-stage studies in B-cell malignancies.
Before joining Infinity Pharmaceuticals, Mr. Pettit held senior roles in Clinical Operations at AMAG Pharmaceuticals, ARIAD Pharmaceuticals, and Coley Pharmaceutical Group.
Mr. Pettit has also held roles in Regulatory Affairs, Program Management, Medical Affairs, and Clinical Research during his long-standing career.
He earned his undergraduate degree in Applied Sciences from the University of Kingston, London, U.K. and holds a Master of Business Administration in Healthcare Management from the University of Phoenix. ■
LATEST MOVES FROM Massachusetts
- PTC appoints Corinna Lathan to board
- J.Jill appoints James S. Scully to board
- Raytheon elects Robert O. Work as director
- Xenetic Biosciences appoints three directors
- Insulet appoints two to board
More inside POST